1/16/2018: Third Dose of MMR Triple Shot Recommended by CDC

The CDC vaccine division, which has been described as building an “an edifice of fraud” by Robert F. Kennedy Jr. , has just recommended a 3rd dose of Merck’s MMR-II vaccine, citing the willingness of parents to accept such a proposal as one part of their rationale.

Add this to the explosive list of shots for babies – most of which are required for school.

In Their Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreakpublished January 12, 2018, CDC cites weak science supporting effectiveness and safety of the approach:

– Three epidemiologic studies among persons who received a third dose during the panic of a mumps outbreak (only one study demonstrated statistical significance)

– Two titer studies measuring mumps virus–specific antibodies after a third dose of MMR (antibodies were increased one month after vaccination, and declined to NEAR BASLINE by 1 year after vaccination). CDC notes that, “In the absence of a correlate of protection that would define the level of antibodies needed to protect a person from mumps disease, the clinical significance of these laboratory findings is unclear.

  • It did not raise any eyebrows that the triply vaccinated young adults suffered from the following conditions: lymphadenopathy (12%), diarrhea (9%), headache (7%), and joint pain (6%). They declared the third dose to be safe and effective, adding:

“Experts concluded that students and parents place high value on preventing mumps and its complications as well as preventing the harms associated with loss of productivity that can occur with mumps disease. Experts also concluded students and parents do not have concerns about safety of a third dose of MMR vaccine.”

The experts were apparently not concerned about the fact that there is absolutely zero liability for the companies that make these products, nor for the government employees and nor for the advisors who design the schedule, which then becomes mandatory for school children.  State tort law is preempted by National Childhood Vaccine Injury Act [42 U. S. C. §300aa–22(b)(1)], which states:

  “[n]o vaccine manufacturer shall be liable in a civil action for damages arising from a vaccine-related injury or death associated with the administration of a vaccine after October 1, 1988, if the injury or death resulted from side-effects that were unavoidable even though the vaccine was properly prepared and was accompanied by proper directions and warnings.”

Should injury occur (vaccines are “unavoidably unsafe” because they represent an artificial intrusion into the immune system), the burden falls on the family.

This parent, for one, has concerns. These shots are being increasingly forced on those who do not want them (see removal of parent philosophical exemption in Vermont and personal belief exemption in California). And there dis no liability. Hello? What are the long term consequences of these recommendations? With no liability, there is no market pressure, no incentive for the “experts” to answer this question.

Mumps outbreaks have been occurring for the last several years now in fully vaccinated populations.

Maybe it is time to seriously investigate the fraud claims of the Merck virologists who allegedly, “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings” – cited the following lawsuits and whistleblower actions:

United States v. Merck & Co., was brought by former Merck scientists alleging, “Merck fraudulently misled the government” https://www.plainsite.org/dockets/mmpl79tu/pennsylvania-eastern-district-court/united-states-of-america-et-al-v-merck-and-co/

Chatom Primary Care v. Merck & Co., “leans heavily on evidence provided by whistleblowers. The suit contends Merck fraudulently monopolized the mumps market http://probeinternational.org/library/wp-content/uploads/2014/09/chatom-v-merck.pdf

CDC employee Whistleblower William Thompson (scientist who publishes safety studies for CDC), admitted on tape that he went along with his CDC colleagues in a 2004, covering-up of data that showed higher rates of autism in African-American boys after receiving the MMR vaccine.

 https://legislature.vermont.gov/assets/Documents/2016/WorkGroups/House%20Health%20Care/Bills/H.98/Witness%20Testimony/H.98~Jennifer%20Stella~William%20Thompson%20Statement~5-6-2015.pdf

Jennifer Stella

Jan. 13, 2018: SIDS and US Infant Mortality Rates

A new study from Johns Hopkins reveals childhood mortality trends from 1961 to 2010 in the United States and 19 economically similar countries.
Researchers found that childhood mortality in the U.S. has been higher than all other peer nations since the 1980s; over the 50-year study period, the U.S.’s “lagging improvement” has amounted to more than 600,000 excess deaths.
Among the leading causes of death for the most recent decade, the researchers say, were premature births and Sudden Infant Death Syndrome (SIDS). Children in the U.S. were three times more likely to die from prematurity at birth and more than twice as likely to die from SIDS.”

 

Jan. 1, 2018: The True Cost of Mass Vaccination

updated, Jan. 5, 2018

What is the true cost of mass vaccination?

Here in tiny little Vermont, where we have  only 625,000 inhabitants, our state  plans to spend almost 17 million dollars buying vaccine product in 2018. Full details on this purchase plan may be found here –http://www.vtvaccine.org/vtvaccine.nsf/WebEvents/71E8875583526E888525816F00471054; with calculation workbook found on this page at “2018 Amended Assessment Workbook V5 10 27 2017.pdf.”
From the workbook, you can see that the state is planning to purchase 60,855 doses for adults and 254,045 doses for children. And although they are also supplementing with federal funds the total spend for Vermont on product alone is nearly $17 million dollars, with the average cost (not including doctors’ billing fees) working out to be over $50 per shot!

Some will say that the dollars spent work out to be some sort of huge cost savings over the long term. It is our understanding there was no bidding process on this. Even so, make no mistake, vaccinations can be a boon to small practices.  In this video, Dr.  Jamie Loehr, MD, FAAFP teaches others how to make a steady income on pushing those vaccines and protecting that bottom line in his video, “Minimizing costs and maximizing reimbursement can make immunizations profitable.” (Fam Pract Manag. 2015 Mar-Apr;22(2):24-29.)

Two bigger questions begin to arise here.

(1) With so many in Vermont not interested** in taking their “recommended vaccines,”  how much of this vaccine product (money) is wasted? and

(2) how many unwanted, unexpected, and unwarned vaccine side effects are costing us even more money in long term health costs?

Of course there is also a human impact.

 

  • On average, about one Vermonter per year is reported disabled after vaccination.
  • In recent years there have been several deaths reported, and dozens of emergency room visits per year in Vermont, reported after vaccination.

On April 24, 2017, The Journal of Transitional Science published one of the first surveys to formally assess the longer-term health outcomes associated with the United States routine childhood vaccination program. Key Findings:
– Vaccinated children were less likely than unvaccinated children to have been diagnosed with chickenpox and pertussis.
– Vaccinated children were more likely than unvaccinated children to have been diagnosed with pneumonia, otitis media, allergies and neuro-developmental disorders such as: learning disabilities, attention deficit hyperactivity disorder and autism spectrum disorder.

The authors called for further research with larger samples and stronger research designs.

Mawson AR, Ray BD, Bhuiyan AR, Jacob B (2017) Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children. J Transl Sci 3: DOI: 10.15761/JTS.1000186

Read the study at: http://www.oatext.com/Pilot-comparative-study-on-the-health-of-vaccinated-and-unvaccinated-6-to-12-year-old-U-S-children.php#Article_Info

The vaccine industry certainly has a lot of help in Vermont in achieving their goals of increasing profits. There is the AAP, Building Bright Futures (an offshoot of the AAP), the ob-gyn (who gives HPV vaccine to patients) in the statehouse who runs bills promoting forced vaccination, the medical industry and drug industry lobbyists, and now we have our own State Health Department spending tens of millions on vaccine doses, promoting vaccines, and advocating for their use to be mandatory (as they did so in 2012 and 2015). In 2015 in Vermont, parents lost their right to file philosophical objections against mandatory school, college and daycare vaccinations. The industry push, which was a blitz that took only 29 days, was fierce.

How shall Vermonters protect themselves from the future prospects of mandatory (forced) vaccines ?

A tiny little baby step is in passing H.247.

From the Caledonian Record:

State Rep. Vicki Strong, R-Albany, is working with those concerned with vaccinations in Vermont, and has proposed a bill, H.247, aimed at requiring the Vermont Department of Health to submit an annual report to the General Assembly “regarding adverse reactions reported to the Vaccine Adverse Event Reporting System.”
 
Strong will work to try and pass the bill next session, she said.
 
The bill would require the report contain: the total number of adverse reactions reported during the previous calendar year; an aggregated reporting of adverse reactions by immunization type, lot number, and age of recipient if the size of the data set allows; the total number and cost of emergency department visits related to reported adverse reactions; the total number of hospitalizations, permanent disabilities, and deaths related to reported adverse reactions; and a summary of activities undertaken by the Department to support Vermonters filing for compensation pursuant to the National Childhood Vaccine Injury Act of 1986.
 
The bill would require the health department to post the report to the legislature on its website and to provide electronic copies to all health care providers administering immunizations in Vermont.
 
Strong said she has friends and constituents who believe their children were injured by vaccines – some severely.
 
“What’s in those immunizations is as critical as the vaccinations themselves, there are preservatives, there’s DNA, there are metals,” said Strong. “They are being questioned around the world, particularly in Europe,” said Strong. “I think we’re behind the times on keeping up with some of the side effects.”
 
“These folks and myself are not anti-vaccination, we’re not anti-doctors or medical research or medical knowledge, we’re just saying there’s a lot going on here,” said Strong. “ What are we sacrificing in the name of immunizations?”
Join us and join the conversation in 2018.

 

**Examples of aggressive mass vaccination campaigns by the State of Vermont on Facebook, encourage people to undergo a medical procedure for the purported benefit of the baby. The comments were clearly coming from many people who do not believe they should be forced to take these shots. Links are provided so that you may read the comments.

Example 1

https://www.facebook.com/HealthVermont/photos/a.172010419500430.37378.168922826475856/1740208376013952/?type=3&theater

Example 2 https://www.facebook.com/HealthVermont/photos/a.172010419500430.37378.168922826475856/1731932290174894/?type=3&theater

Example 3 https://www.facebook.com/HealthVermont/photos/a.172010419500430.37378.168922826475856/1724494240918699/?type=3&theater

Vaccination should never be mandatory  it should always be a choice.

Jennifer Stella

 

Dec. 18, 2017: We need to talk.

We need to talk about vaccine injury awareness.

VAERS Bill, H.247, in the Vermont House Healthcare Committee will increase transparency and awareness of consumer vaccine injury reports filed by Vermonters. The bill will improve oversight upon the unseen outcomes and hidden costs of Vermont’s Immunization Program. While not all reports can be proven to be caused by the vaccine(s) given, underreporting and failure to recognize vaccine injury is a widespread problem. Ask your elected rep to support H.247~!

 

Recent Vermont VAERS reports – examples.

This poor baby got EIGHT (8) vaccines at once. She developed a high fever and was unwell for a week. Are there any long term effects? VAERS ID 702895:

This four-year old was given TEN vaccines at one time on Oct. 2, 2017. The report is made about the ensuing fever and vomiting the child experienced. VAERS ID 718104

Do you have a vaccine injury experience to share or a VAERS report filed?

Please contact us. We need to talk.

Who is responsible for following these reactions? What are the long term outcomes? What are the associated costs?


 

 

Today’s vaccine schedule is nothing like what it used to be.

For example, many vaccines are given in combination, many now contain aluminum adjuvant – and the emerging science is very concerning. This year, scientists from the University of Keele and King’s College of London published a peer-reviewed report on Aluminum (Al) in brain tissue in autism. They measured Al in brain tissue in brain tissue from donors who died with a diagnosis of Autism Spectrum Disorder,and they have identified the location of Al in these tissues. Their findings are troubling, since many vaccines contain aluminum (Al) adjuvants – typically Al hydroxide and/or Al phosphate nano particles.

We encourage you to be open and not closed towards understanding this very complex topic. There is a big difference between supporting vaccination versus supporting mandatory vaccination, particularly when there is the potential for grave and untoward side effects.

At our event on September 8th, people from all over New England told their stories.

Their experiences as vaccine consumers deserve to be heard.

Every body should be concerned about vaccine safety awareness.

Let’s talk!

 

 

December 1, 2017

Philippines Suspends Dengue Shots After Drug Firm’s Warning

The New York Times Reports:

MANILA — The Philippines suspended its school-based dengue immunization program on Friday after the French pharmaceutical giant Sanofi warned that its flagship vaccine, Dengvaxia, had been found to pose health risks in people not previously infected.

The suspension came after health experts expressed worries about Sanofi’s announcement this week.

The company said further clinical studies had revealed that, in those who had previously had dengue, the vaccine could prevent repeat infection. But for those who had not had dengue, and were vaccinated and later became infected, “more cases of severe disease could occur,” Sanofi said in the advisory.

With more than 740,000 elementary school students in the Philippines having already received Dengvaxia vaccinations, the government decided to halt the program for the time being.

The Philippine health secretary, Francisco Duque, said the program would be “on hold while review consultations are on the way.” He added that the government would seek help from medical experts outside the Philippines, including from the World Health Organization.

Dengue is the most widespread mosquito-borne disease in the world, with nearly 400 million people infected every year. There are four dengue viruses, or serotypes, and most people who are infected recover and become immune to the first serotype they had. In some cases, a later infection with a different serotype can lead to a severe hemorrhagic fever. About 25,000 people die every year from hemorrhagic fevers arising from the disease.

Mr. Duque said that, with an average of 200,000 people infected with dengue every year in the Philippines, vaccination was “essential.” He said that the Department of Health would be stepping up its monitoring efforts to ensure public safety and that the department’s legal division was studying what to do with the Sanofi contract and how to deal with the hundreds of thousands of children who may have been put at risk.

Mr. Duque said that government officials had been asked to coordinate with community health experts to identify and monitor the children. He said a post-vaccination surveillance program would last for five years.

“I hope that this development will not in any way affect the expanded program of immunization because there are countless number of lives that have been saved,” Mr. Duque said, adding that 7 billion Philippine pesos, or about $140 million, had been budgeted for all government vaccination programs for the year, up from 340 million pesos in 2006.

He would not say when the program was likely to be restarted or what steps would be necessary to allow resumption.

“We need to go back quite a long way to really put the facts together,” Mr. Duque said. “Until that is available, we can’t answer all your questions with definitive responses.”

He said the vaccines that were now in stock would not be allowed to be sold unless the labels were changed to reflect the latest advisory.

Photo

 
Sanofi, manufacturer of Dengvaxia, said the drug posed a risk to people who had not previously been infected. CreditNoel Celis/Agence France-Presse — Getty Images 

Sanofi representatives in Manila were not immediately available to comment on Friday.

The Philippines became the first country in Asia to approve the commercial sale of Dengvaxia, in December 2015. Dengvaxia is the first dengue vaccine developed by Sanofi.

Health advocates in the Philippines first raised the alarm over Dengvaxia when the government announced in April last year that it would be used in the school immunization program despite the fact that it was a relatively new drug with possible unknown effects. But the government continued, budgeting about $70 million for the program.

The government has defended its use of the vaccine, saying that the treatment had undergone extensive studies and stressing that it was approved for use by the World Health Organization. The first hint that there could be something wrong was in April last year, when an 11-year-old boy with congenital heart disease died after receiving a Dengvaxia shot, but the government worked to distance the drug from the death.

Nancy Binay, a legislator in the Philippine Senate, said she was alarmed at the drug’s potential impact on public health and urged the health authorities and Sanofi to “launch a nationwide medical advisory and information drive” to contact parents whose children had been given Dengvaxia.

The recently released Sanofi medical report was “deeply shocking and disturbing,” Senator Binay said.

She said it was “sad” that the health department ignored the warnings about the lack of patient safety and research integrity in the Dengvaxia tests. “Safety should always be the paramount concern when it comes to any immunization program,” she said.

Senator Binay called on the pharmaceutical giant to explain what it meant when it warned of “severe disease.”

“We don’t want the warning to the public to come too little, too late,” she said. “Obviously, there were shortfalls and gaps in the vaccine’s safety profile, and I believe Sanofi is morally and ethically obliged to inform the public what severe diseases came out in their clinical tests.”

Dr. Anthony Leachon, an independent director at PhilHealth, a government medical insurance body, said the Philippine medical community had expressed alarm at the government’s use of the vaccine.

He said that as early as last year medical experts had told the government that there was “lingering uncertainty” about the long-term effects of the vaccine, but that their concerns had apparently been ignored.

“Evidence from manufacturer’s trials shows that there may be a paradoxical increase in the incidence of severe dengue beginning a few years after children are vaccinated, and possibly continuing for the rest of their lives,” Dr. Leachon said.

The clinical trials on the dengue vaccine were designed specifically to assess this “and sadly, this danger has been confirmed,” he said.

“Many parents, teachers and health care workers claim they were never fully informed about the benefits and potential side effects of the vaccine,” Dr. Leachon added.

Nov. 28, 2017

Scientists from University of Keele, and King’s College of London Report on “Aluminium in brain tissue in autism.”

new!
Vaccine Aluminum Adjuvant:
Safety Problems Ignored

Scientists from University of Keele, and King’s College of London Report on “Aluminium in brain tissue in autism.”

 
For the first time, scientists report on aluminum in brain tissue from donors who died with a diagnosis of Autism Spectrum Disorder. They have measured aluminum in brain tissue in autism and identified the location of aluminum in these tissues.
 
These findings are troubling, since many vaccines contain aluminum (Al) adjuvants – typically Al hydroxide and/or Al phosphate nano particles.
 
“These are some of the highest values for aluminium in human brain tissue yet recorded and one has to question why, for example, the aluminium content of the occipital lobe of a 15 year old boy would be 8.74 (11.59) μg/g dry wt.?” – Mold Matthew, Umar Dorcas, King Andrew, Exley Christopher. Aluminium in brain tissue in autism. Journal of Trace Elements in Medicine and Biologyhttps://doi.org/10.1016/j.jtemb.2017.11.012.

Article in press, available online 26 November 2017.  (Note: Articles in Press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.)

“The research does not infer that Al is a cause of autism, “said Exley, who also authored Human Exposure to Aluminum. “But these very high concentrations of a neurotoxin in brain tissue are not going to be benign and will contribute to neurodegeneration in affected tissues.” Read more at :  The Children’s Medical Safety Research Institute
 
Article in press, available online 26 November 2017.  (Note: Articles in Press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.)

Full accepted manuscript: keele-kings-Aluminium in brain tissue in autism

 

-Jennifer Stella

After All These Years, FDA is Still “Asleep at the Switch”

By Lyn Redwood, RN, MSN, Executive Director

Background: Peter Patriarca, an FDA employee, admitted back in 1999, in a confidential e-mail obtained through FOIA, that, “… the greatest point of vulnerability on this issue is that the systematic review of thimerosal in vaccines by the FDA could have been done years ago and on an ongoing basis as the childhood immunization schedule became more complex.  The calculations done by FDA are not complex. I’m not sure if there will be an easy way out of the potential perception that the FDA, CDC and immunization policy bodies may have been “asleep at the switch” re: thimerosal until now”. 

Since 1999, an entire generation of children both in the US and internationally has continued to be exposed to thimerosal – and it is time for this to stop.  Nobody should be exposed to a known neurotoxin.

An Ongoing Saga: On March 30th of this year, Robert F. Kennedy, Jr., and the World Mercury Project team met with the Director of the FDA’s Center for Biologics Evaluation and Research (CBER) Dr. Peter Marks, M.D., Ph.D. and his colleagues to discuss the agency’s ongoing refusal to ban thimerosal, a mercury-based preservative, from vaccines in the United States. CBER is the division of the FDA responsible for approving and monitoring the safety of all biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.

At the meeting, we presented a large amount of research showing the toxicity of thimerosal in humans, animals and cellular models, including at levels similar to those resulting from vaccine exposures.  We expressed our alarm regarding the total lack of adequate safety testing of thimerosal prior to licensure, especially given its current use in vaccines approved for infants and pregnant women and its worldwide use in millions of vaccines given to children, particularly in developing countries.  Dr. Marks promised to look over the studies and seriously consider our concerns.

Here is the correspondence that followed:

April 24, 2017: Lyn Redwood Letter to Peter Marks, FDA [PDF]

July 11, 2017: Peter Marks Letter to Lyn Redwood [PDF]

November 13, 2017: Lyn Redwood Letter to Peter Marks, FDA [PDF][Article]

One FDA Hand Doesn’t Know What the Other FDA Hand is Doing

It seems ludicrous for one arm of the FDA, the Center for Drug Evaluation and Research (CDER), which regulates over-the-counter products to find that thimerosal and other mercury products are not generally recognized as safe and effective (GRASE) while CBER allows their widespread use in over 120 vaccines and other prescription products. In 1998, FDA issued final rules banning thimerosal and mercury product use in over-the-counter products.  Our goal at World Mercury Project is to extend that ban to all use of mercury in medical products both in the United States and worldwide.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the World Mercury Project. Your donation will help to support us in our efforts.

Autoimmune disease: Better studies needed.

For those with rheumatoid arthritis (RA) in the family: Researchers from three different universities in China, representing the fields of rheumatology, immunology, endocrinology and epidemiology, recently performed a meta-analysis . They found an increased risk of lupus and an increased risk RA – after vaccination. Autoimmunity Reviews, July, 2017: http://www.sciencedirect.com/science/article/pii/S1568997217301349?via%3Dihub

Citizens for informed consent file petition for hearing on vaccine evidence

Vermont citizens for informed consent
(1) File petition for hearing on vaccine evidence
(2) Send notice to US DHHS 

Reference documents:
(1) http://www.vaxchoicevt.com/wp-content/uploads/2017/10/Press-release-Oct-12-2017-3.htm; and
(2) http://icandecide.com/white-papers/ICAN-HHS-Notice.pdf

News Reports: